COVID-19: Vaccine Program | Testing | Visitor Guidelines | Information for Employees
The Intellectual Property Owners Education Foundation (IPOEF) awards the prestigious Inventor of the Year award to Dr. Cato T. Laurencin for his groundbreaking innovation in regenerative engineering. Dr. Laurencin’s work has led to clinical systems for bone, cartilage, ligament, and tendon healing and regeneration.
The 1st edition of Research.com ranking of the best scientists in the arena of materials science is based on data consolidated from various data sources, including data sources including OpenAlex and CrossRef. The bibliometric data for estimating the citation-based metrics were gathered on December 6th, 2021.
Position in the ranking is based on a scientist’s D- index (Discipline H- index), which only includes papers and citation values for an examined discipline.
Please see the article link here:
https://ctbythenumbers.news/ctnews/uconns-laurencin-elected-to-national-academy-of-medicine-council-groundbreaking-institute-for-regenerative-engineering-launched
On May 10 the University of Connecticut hosted the first The Truth, Racial Healing, and Transformation (TRHT) Research Day at its UConn Hartford campus. This research day is a part of a series of events centered around TRHT and is sponsored by UConn’s Office for Diversity and Inclusion.
The Cato T. Laurencin Institute at UConn School of Medicine has many programs and initiatives that revolve around solving health disparities. The institute reports on the scholarly progress of work to understand, address, and eliminate health disparities based on race and ethnicity.
Read the full article here: https://today.uconn.edu/2023/06/uconn-health-faculty-and-students-at-the-inaugural-truth-racial-healing-and-transformation-trht-research-day/
UConn Health scientists describe a new method that can promote regrowth of long bones more affordably and with fewer side effects than other techniques
University Professor Dr. Cato T. Laurencin and colleagues at UConn School of Medicine used a slightly different approach to encourage bone growth. They wanted to release a medicine directly where new bone needed to grow, and do it in a short period of time.
Read the full article here: https://today.uconn.edu/2023/05/healing-big-broken-bones-with-a-small-molecule/
A new paper in the Proceedings of the National Academy of Sciences (PNAS) is reporting that a graphene/polymer matrix embedded into shoulder muscle can prevent re-tear injuries. The technique uses advanced materials to encourage muscle growth in rotator cuff muscles and address the real problem: muscle degeneration and fat accumulation. Read more by clicking the link below.
Advanced rotator cuff treatment repairs and protects shoulder muscle from reinjury – An article done by Canada Today
Congrats to our Year Two YIIP Students :
Romoye Sohan
University Of Connecticut
B,S; Biological Sciences
Stephanie Chinwo
University Of Connecticut
B,S; Biological Sciences
Sandro Cloiseau
University Of Connecticut
B,S; Biological Sciences
On March 28 Dr. Cato T. Laurencin, the University Professor and Albert and Wilda Van Dusen Distinguished Endowed Professor at the University of Connecticut, received the 2023 Priestley Medal. This is the highest honor of the American Chemical Society. He was honored “for pioneering, breakthrough work on polymeric materials and polymer composites for biologic use, and for leadership in inclusion, diversity, equity, anti-racism and learning (IDEAL).”
In chemistry and materials science, Laurencin is a pioneer in polymeric materials chemistry, and polymeric materials science engineering for musculoskeletal systems. He produced seminal research work and discoveries in patents and papers on polymeric nanofiber technology, ushering in the field of polymeric nanomaterials for tissue regeneration. His work in published papers and patents focusing on polymer-ceramic systems inspired the development of biocomposite materials including interference screws for which he was named “One of the 100 Engineers of the Modern Era” by the American Institute of Chemical Engineers at their centennial celebration. Fundamental research on polymeric fiber system for soft tissue regeneration has led to a number of soft tissue regenerative systems including the Laurencin-Copper (LC) bioengineered anterior cruciate ligament, now in humans. His work on engineered materials for soft tissue regeneration was highlighted by National Geographic Magazine in its “100 Scientific Discoveries that Changed the World” edition. He has worked with industry on the development and understanding of systems combining polymeric materials and allograft human tissue, creating technologies helping patients throughout the world.
Read the full article: https://today.uconn.edu/2023/03/dr-cato-t-laurencin-awarded-by-the-american-chemical-society-receiving-the-2023-priestley-medal/
Professor Cato T Laurencin was invited to the Vatican to meet with Pope Francis and to discuss his work on Regenerative Engineering. During the visit. Dr. Laurencin gave Pope Francis an honorary Cato T. Laurencin Regenerative Engineering Founder’s Award Medal.
This medal, endowed by the Regenerative Engineering Society and the American Institute of Chemical Engineers Foundation, recognizes leadership in the science and practice of convergence research as applied to regeneration.
Dr. Laurencin has made seminal contributions to tissue regeneration, biomaterials science, and nanotechnology. He founded the field of regenerative engineering and has been considered to be the foremost engineer-physician-scientist in the world. His groundbreaking achievements have led to important advances in improving human life. He is the first surgeon to be elected to the National Academy of Sciences, the National Academy of Engineering, the National Academy of Medicine and the National Academy of Inventors. During his visit to the Vatican, Dr. Laurencin provided an important lecture on the field of Regenerative Engineering. He discussed the Hartford Engineering a Limb project aimed at addressing the grand challenge of whole limb regeneration. Laurencin is the University Professor and Albert and Wilda Van Dusen Distinguished Endowed Professor of Orthopaedic Surgery at the University of Connecticut.
We are excited to announce a new institute. It is entitled The Cato T. Laurencin Institute for Regenerative Engineering. “This initiative is only one of the countless number of Dr. Laurencin’s contributions to the development of science and engineering”, says Provost Anne D’Alleva.
Regenerative engineering is a field founded by Professor Cato T. Laurencin. It is described as the convergence of advanced materials sciences, stems cell science, physics, developmental biology, and clinical translation for the regeneration of complex tissues and organ systems. The Cato T. Laurencin Institute for Regenerative Engineering represents a transdisciplinary effort at UConn with a focus on the musculoskeletal area. The Institute integrates medicine, engineering, surgery, biology, physics, chemistry, and statistics/machine learning to enable a powerful platform for addressing scientific and medical problems in the regeneration and healing of complex tissues, organs, or organ systems.
The Cato T. Laurencin Institute of Regenerative Engineering holds to the pillars developed for the first Cato T. Laurencin Institute, namely:
Excellence in Science
Anti-Racism and Justice
Sponsorship and Mentorship
International, National, and Community Action
Transformative Technologies for Humanity
Economic Value Creation
In addition to this endeavor, Dr. Laurencin has created a ground-breaking project. It is entitled, Cato T. Laurencin Innovative Convergence Ventures (CTLICV). The CTLICV invests in next-generation companies based on innovative research conducted created within the Institute and its collaborating partners across UConn and greater university and corporate communities. We seek strong co-investor syndicates to develop products across a range of categories including regenerative engineering, drugs, devices, diagnostics, and digital health. The intent is to fast-track innovative research from bench to bed, with measurable impact on public health, quality of life, reducing societal disparity, and economic development.
CTLICV’s investments are directed at the seed and Series A stages, where it attracts capital and talent into the most difficult-to-fund phase of company development. When we invest, we expect to support each portfolio company through its entire financing lifecycle. We leverage the portfolio investment activity and internal/external relationships to further the mission vision and values of the Institute. Additionally, the fund taps into our experience in starting and growing companies, our expertise in the medical industry, and our network of scientific and business talent to build great companies.
The scientific and educational opportunities being pursued now and in the future at UConn will enable innovation and problem-solving beyond conventional academic boundaries. A core mission of UConn is precisely to foster new ways of thinking and new approaches to answers in medicine, science, engineering, and technology. We invite you to engage with us as we continue our work here at UConn.
